Gabe Woodward - 25 Jan 2023 Form 3 Insider Report for GENELUX CORP (GNLX)

Role
Director
Signature
/s/ Sean Ryder, Attorney-in-Fact
Issuer symbol
GNLX
Transactions as of
25 Jan 2023
Net transactions value
$0
Form type
3
Filing time
25 Jan 2023, 18:30:53 UTC
Next filing
30 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GNLX Series I Preferred Stock 25 Jan 2023 Common Stock 5,378 by Olympic Xploration F1
holding GNLX Series J Preferred Stock 25 Jan 2023 Common Stock 3,186 Direct F2
holding GNLX Series K Preferred Stock 25 Jan 2023 Common Stock 2,798 by Trust F3, F4
holding GNLX Stock Option (right to buy) 25 Jan 2023 Common Stock 8,333 $9.00 by Spouse F5
holding GNLX Stock Option (right to buy) 25 Jan 2023 Common Stock 8,333 $9.00 by Spouse F5
holding GNLX Stock Option (right to buy) 25 Jan 2023 Common Stock 8,333 $9.00 by Spouse F5
holding GNLX Stock Option (right to buy) 25 Jan 2023 Common Stock 8,333 $9.00 by Spouse F5
holding GNLX Stock Option (right to buy) 25 Jan 2023 Common Stock 25,000 $10.50 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series I Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.241082248 shares of Common Stock for each 3 shares of Series I Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.
F2 The Series J Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.36557561 shares of Common Stock for each 3 shares of Series J Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.
F3 The Series K Preferred Stock has no expiration date and will automatically convert into shares of Common Stock at a conversion ratio of 1.399411327 shares of Common Stock for each 3 shares of Series K Preferred Stock for no additional consideration upon the closing of the Issuer's initial public offering.
F4 By Gabe Woodward, Trustee of The Gabe and Staci Woodward Family Trust dated June 5, 2009.
F5 Immediately exercisable.